Lowest-Rated StocksLowest-RatedNASDAQ:DOCS Doximity (DOCS) Stock Forecast, Price & News $32.65 -1.41 (-4.14%) (As of 06/7/2023 ET) Add Compare Share Share Today's Range$32.65▼$34.9750-Day Range$30.61▼$36.7552-Week Range$22.91▼$47.46Volume1.61 million shsAverage Volume1.87 million shsMarket Capitalization$6.36 billionP/E Ratio62.79Dividend YieldN/APrice Target$36.82 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Doximity MarketRank™ ForecastAnalyst RatingHold2.00 Rating ScoreUpside/Downside12.8% Upside$36.82 Price TargetShort InterestN/ADividend StrengthN/ASustainabilityN/ANews Sentiment0.47Based on 17 Articles This WeekInsider TradingSelling Shares$262,500 Sold Last QuarterProj. Earnings Growth23.08%From $0.65 to $0.80 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.26 out of 5 starsMedical Sector258th out of 981 stocksCustom Computer Programming Services Industry10th out of 25 stocks 2.0 Analyst's Opinion Consensus RatingDoximity has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 3 buy ratings, 4 hold ratings, and 3 sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $36.82, Doximity has a forecasted upside of 12.8% from its current price of $32.65.Amount of Analyst CoverageDoximity has only been the subject of 1 research reports in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for DOCS. Previous Next 0.0 Dividend Strength Dividend YieldDoximity does not currently pay a dividend.Dividend GrowthDoximity does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for DOCS. Previous Next 2.5 News and Social Media Coverage News SentimentDoximity has a news sentiment score of 0.47. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 17 news articles for Doximity this week, compared to 4 articles on an average week.Search InterestOnly 12 people have searched for DOCS on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.MarketBeat Follows8 people have added Doximity to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Doximity insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $262,500.00 in company stock.Percentage Held by Insiders45.21% of the stock of Doximity is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions52.48% of the stock of Doximity is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Doximity are expected to grow by 23.08% in the coming year, from $0.65 to $0.80 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Doximity is 62.79, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 146.84.Price to Earnings Ratio vs. SectorThe P/E ratio of Doximity is 62.79, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 147.21.Price to Earnings Growth RatioDoximity has a PEG Ratio of 11.35. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioDoximity has a P/B Ratio of 6.56. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Doximity (NASDAQ:DOCS) StockDoximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.Read More Receive DOCS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Doximity and its competitors with MarketBeat's FREE daily newsletter. Email Address DOCS Stock News HeadlinesMay 23, 2023 | marketbeat.comDoximity is an Overlooked Medical Ecosystem AI Play Doximity Inc. (NASDAQ: DOCS) is a digital professional social network platform for medical practitioners. It’s a medical community networking platform likeJune 8, 2023 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Doximity (DOCS), Biomea Fusion (BMEA)June 8, 2023 | Edge On The Street (Ad)Graphite Shortage Could Derail the $7 Trillion EV TransitionGraphite (not lithium) is expected to see the largest increase in demand of all battery metals over the next decade. But projections warn of an 8 million ton shortfall of graphite by 2040. That's why 97 more graphite mines are needed just to keep up with battery production for the $7 trillion transition to electric vehicles.June 7, 2023 | msn.comNeedham Reiterates Doximity Inc - (DOCS) Prior RecommendationJune 7, 2023 | markets.businessinsider.comDoximity (DOCS) Receives a Buy from Canaccord GenuityJune 7, 2023 | msn.comDoximity Aims for $1B Topline In 2028June 7, 2023 | americanbankingnews.comStock Traders Buy High Volume of Doximity Call Options (NASDAQ:DOCS)June 6, 2023 | msn.com3 Top Healthcare Stocks to Buy for JuneJune 8, 2023 | Edge On The Street (Ad)New "Mined in America" Lithium Opportunities?The average electric vehicle needs 138 pounds of lithium carbonate for its battery components. But China currently controls the entire lithium supply chain.June 5, 2023 | msn.comThe Latest Analyst Ratings for DoximityJune 5, 2023 | msn.comTruist Securities Maintains Doximity Inc - (DOCS) Hold RecommendationJune 5, 2023 | americanbankingnews.comDoximity (NASDAQ:DOCS) Price Target Lowered to $33.00 at Truist FinancialJune 4, 2023 | americanbankingnews.comDoximity, Inc. (NASDAQ:DOCS) Receives $35.80 Average PT from BrokeragesMay 28, 2023 | finance.yahoo.com1 No-Brainer Stock to Buy With $100 Right NowMay 26, 2023 | finance.yahoo.comDoximity (DOCS) Reports Q4 Earnings: What Key Metrics Have to SayMay 23, 2023 | americanbankingnews.comHead-To-Head Contrast: Doximity (NASDAQ:DOCS) & Symbolic Logic (NASDAQ:EVOL)May 21, 2023 | americanbankingnews.comDoximity (NASDAQ:DOCS) PT Lowered to $32.00May 19, 2023 | msn.comMorgan Stanley Maintains Doximity Inc - (DOCS) Underweight RecommendationMay 19, 2023 | americanbankingnews.comDoximity (NASDAQ:DOCS) Shares Gap Down on Analyst DowngradeMay 18, 2023 | msn.comEvercore ISI Group Maintains Doximity Inc - (DOCS) In-Line RecommendationMay 18, 2023 | msn.comNeedham Reiterates Doximity Inc - (DOCS) Buy RecommendationMay 17, 2023 | bloomberg.comTarget, Energy, Debt Ceiling, and DoximityMay 17, 2023 | msn.comWhy Doximity Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionMay 17, 2023 | theglobeandmail.comWhy Doximity (DOCS) Shares Are Sliding TodayMay 17, 2023 | markets.businessinsider.comNeedham Keeps Their Buy Rating on Doximity (DOCS)May 17, 2023 | msn.comWhat's Going On With Doximity Stock Wednesday?May 17, 2023 | markets.businessinsider.comDoximity (DOCS) Receives a Hold from Wells FargoSee More Headlines DOCS Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DOCS Company Calendar Last Earnings5/16/2023Today6/07/2023Next Earnings (Estimated)8/03/2023Fiscal Year End3/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Custom computer programming services Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:DOCS CUSIPN/A CIK1516513 Webwww.doximity.com Phone650-549-4330FaxN/AEmployees850Year FoundedN/APrice Target and Rating Average Stock Price Forecast$36.82 High Stock Price Forecast$49.00 Low Stock Price Forecast$29.00 Forecasted Upside/Downside+12.8%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage10 Analysts Profitability EPS (Most Recent Fiscal Year)$0.52 Trailing P/E Ratio62.79 Forward P/E Ratio50.23 P/E Growth11.35Net Income$112.82 million Net Margins26.92% Pretax Margin31.78% Return on Equity12.74% Return on Assets10.94% Debt Debt-to-Equity RatioN/A Current Ratio6.99 Quick Ratio6.99 Sales & Book Value Annual Sales$419.05 million Price / Sales15.17 Cash Flow$0.69 per share Price / Cash Flow47.27 Book Value$4.98 per share Price / Book6.56Miscellaneous Outstanding Shares194,670,000Free Float106,658,000Market Cap$6.36 billion OptionableNot Optionable Beta0.86 Key ExecutivesMr. Jeffrey A. Tangney (Age 49)Co-Founder, CEO & Chairperson Comp: $243.39kMs. Anna Bryson (Age 32)Chief Financial Officer Comp: $403.21kMr. Paul Jorgensen (Age 52)Chief Revenue Officer Comp: $647.99kDr. Nate Gross M.D.Co-Founder & Chief Strategy OfficerMs. Shari BuckCo-founder and SVP People & OpsMr. Jey BalachandranChief Technology OfficerMr. Perry Scott GoldHead of Investor RelationsMs. Jennifer W. Chaloemtiarana (Age 54)Gen. Counsel & Corp. Sec. Jim RivasHead of Corp. CommunicationsMr. Bruno MirandaSr. VP of EngineeringMore ExecutivesKey CompetitorsMedpaceNASDAQ:MEDPBausch + LombNYSE:BLCO10x GenomicsNASDAQ:TXGExelixisNASDAQ:EXELEncompass HealthNYSE:EHCView All CompetitorsInsiders & InstitutionsEmpower Advisory Group LLCBought 14,500 shares on 5/25/2023Ownership: 0.007%Ameriprise Financial Inc.Sold 961,437 shares on 5/22/2023Ownership: 0.678%JPMorgan Chase & Co.Sold 92,678 shares on 5/18/2023Ownership: 0.192%New York State Common Retirement FundSold 6,500 shares on 5/18/2023Ownership: 0.055%Advisory Services Network LLCSold 341 shares on 5/17/2023Ownership: 0.000%View All Insider TransactionsView All Institutional Transactions DOCS Stock - Frequently Asked Questions Should I buy or sell Doximity stock right now? 10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Doximity in the last twelve months. There are currently 3 sell ratings, 4 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" DOCS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DOCS, but not buy additional shares or sell existing shares. View DOCS analyst ratings or view top-rated stocks. What is Doximity's stock price forecast for 2023? 10 brokers have issued 1 year target prices for Doximity's stock. Their DOCS share price forecasts range from $29.00 to $49.00. On average, they anticipate the company's share price to reach $36.82 in the next year. This suggests a possible upside of 12.8% from the stock's current price. View analysts price targets for DOCS or view top-rated stocks among Wall Street analysts. How have DOCS shares performed in 2023? Doximity's stock was trading at $33.56 on January 1st, 2023. Since then, DOCS shares have decreased by 2.7% and is now trading at $32.65. View the best growth stocks for 2023 here. When is Doximity's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023. View our DOCS earnings forecast. How were Doximity's earnings last quarter? Doximity, Inc. (NASDAQ:DOCS) released its quarterly earnings data on Tuesday, May, 16th. The company reported $0.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.13 by $0.02. The firm earned $110.97 million during the quarter, compared to analyst estimates of $110.11 million. Doximity had a net margin of 26.92% and a trailing twelve-month return on equity of 12.74%. What ETFs hold Doximity's stock? ETFs with the largest weight of Doximity (NASDAQ:DOCS) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), Jacob Forward ETF (JFWD), Janus Henderson Small Cap Growth Alpha ETF (JSML), Fidelity Digital Health ETF (FDHT), Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), Harbor Corporate Culture Leaders ETF (HAPY).Renaissance IPO ETF (IPO). What guidance has Doximity issued on next quarter's earnings? Doximity updated its FY 2028 earnings guidance on Wednesday, June, 7th. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.00B-. When did Doximity IPO? (DOCS) raised $501 million in an initial public offering (IPO) on Thursday, June 24th 2021. The company issued 23,300,000 shares at $20.00-$23.00 per share. Morgan Stanley, Goldman Sachs and J.P. Morgan Securities acted as the underwriters for the IPO and Piper Sandler, William Blair, Canaccord and Raymond James were co-managers. What is Doximity's stock symbol? Doximity trades on the NASDAQ under the ticker symbol "DOCS." Who are Doximity's major shareholders? Doximity's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Clearbridge Investments LLC (3.50%), BlackRock Inc. (2.82%), FMR LLC (2.71%), Baillie Gifford & Co. (2.27%), Price T Rowe Associates Inc. MD (1.22%) and Credit Suisse AG (1.07%). Insiders that own company stock include Anna Bryson, Gilbert H Kliman, Interwest Partners X Lp, Joseph B Kleine, Kevin Spain, Kira Scherer Wampler, Paul W Jorgensen and Timothy S Cabral. View institutional ownership trends. How do I buy shares of Doximity? Shares of DOCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Doximity's stock price today? One share of DOCS stock can currently be purchased for approximately $32.65. How much money does Doximity make? Doximity (NASDAQ:DOCS) has a market capitalization of $6.36 billion and generates $419.05 million in revenue each year. The company earns $112.82 million in net income (profit) each year or $0.52 on an earnings per share basis. How many employees does Doximity have? The company employs 850 workers across the globe. How can I contact Doximity? The official website for the company is www.doximity.com. The company can be reached via phone at 650-549-4330 or via email at ir@doximity.com. This page (NASDAQ:DOCS) was last updated on 6/8/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Doximity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.